IL80896A - Synthetic polypeptides which duplicate amino acid sequences of herpes simplex virus envelope glycoproteins and vaccine composition and diagnostic reagent containing them - Google Patents

Synthetic polypeptides which duplicate amino acid sequences of herpes simplex virus envelope glycoproteins and vaccine composition and diagnostic reagent containing them

Info

Publication number
IL80896A
IL80896A IL80896A IL8089683A IL80896A IL 80896 A IL80896 A IL 80896A IL 80896 A IL80896 A IL 80896A IL 8089683 A IL8089683 A IL 8089683A IL 80896 A IL80896 A IL 80896A
Authority
IL
Israel
Prior art keywords
amino acid
acid sequences
herpes simplex
simplex virus
vaccine composition
Prior art date
Application number
IL80896A
Other languages
English (en)
Original Assignee
University Patents Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26996451&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL80896(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by University Patents Inc filed Critical University Patents Inc
Publication of IL80896A publication Critical patent/IL80896A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/22—Viral peptide or viral protein
    • Y10S930/224—Herpes related

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
IL80896A 1982-02-18 1983-02-16 Synthetic polypeptides which duplicate amino acid sequences of herpes simplex virus envelope glycoproteins and vaccine composition and diagnostic reagent containing them IL80896A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35002182A 1982-02-18 1982-02-18
US06/463,141 US4762708A (en) 1982-02-18 1983-02-04 Materials and methods for herpes simplex virus vaccination
IL67930A IL67930A (en) 1982-02-18 1983-02-16 Immunologically active preparation of herpes simplex virus envelope glycoprotein gd-1 and vaccine composition and diagnostic reagent comprising it

Publications (1)

Publication Number Publication Date
IL80896A true IL80896A (en) 1990-02-09

Family

ID=26996451

Family Applications (5)

Application Number Title Priority Date Filing Date
IL80896A IL80896A (en) 1982-02-18 1983-02-16 Synthetic polypeptides which duplicate amino acid sequences of herpes simplex virus envelope glycoproteins and vaccine composition and diagnostic reagent containing them
IL67930A IL67930A (en) 1982-02-18 1983-02-16 Immunologically active preparation of herpes simplex virus envelope glycoprotein gd-1 and vaccine composition and diagnostic reagent comprising it
IL80895A IL80895A (en) 1982-02-18 1983-02-16 Immunologically active preparation of herpes simplex virus envelope glycoprotein gd-2 and vaccine composition and diagnostic reagent comprising it
IL80895A IL80895A0 (en) 1982-02-18 1986-12-07 Material and methods for herpes simplex virus vaccination and diagnosis based on gd-2 glycoprotein
IL80896A IL80896A0 (en) 1982-02-18 1986-12-07 Novel synthetic polypeptides

Family Applications After (4)

Application Number Title Priority Date Filing Date
IL67930A IL67930A (en) 1982-02-18 1983-02-16 Immunologically active preparation of herpes simplex virus envelope glycoprotein gd-1 and vaccine composition and diagnostic reagent comprising it
IL80895A IL80895A (en) 1982-02-18 1983-02-16 Immunologically active preparation of herpes simplex virus envelope glycoprotein gd-2 and vaccine composition and diagnostic reagent comprising it
IL80895A IL80895A0 (en) 1982-02-18 1986-12-07 Material and methods for herpes simplex virus vaccination and diagnosis based on gd-2 glycoprotein
IL80896A IL80896A0 (en) 1982-02-18 1986-12-07 Novel synthetic polypeptides

Country Status (20)

Country Link
US (1) US4762708A (es)
EP (1) EP0101506B1 (es)
JP (3) JP2665332B2 (es)
KR (1) KR910006889B1 (es)
AR (1) AR231496A1 (es)
AT (1) ATE54827T1 (es)
AU (1) AU554710B2 (es)
CA (1) CA1236774A (es)
DE (1) DE3381761D1 (es)
DK (1) DK172619B1 (es)
ES (1) ES519875A0 (es)
FI (2) FI73885C (es)
GR (1) GR77900B (es)
HU (1) HU195734B (es)
IE (1) IE56479B1 (es)
IL (5) IL80896A (es)
NO (2) NO162366B (es)
NZ (1) NZ220771A (es)
PH (1) PH25689A (es)
WO (1) WO1983002897A1 (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4540669A (en) * 1980-09-11 1985-09-10 Merck & Co., Inc. Herpes simplex type I subunit vaccine
US5149660A (en) * 1982-02-18 1992-09-22 University Patents, Inc. Diagnostic reagents relating to herpes simplex virus
NZ209308A (en) * 1983-08-30 1991-08-27 Genentech Inc Vaccine against hsv involving a truncated membrane-free derivative of a membrane-bound protein
NZ209307A (en) * 1983-08-30 1990-07-26 Genentech Inc Diagnostic product: antigenic peptide produced by recombinant dna techniques
US7264817B1 (en) 1983-08-30 2007-09-04 Genentech, Inc. Immunogenic composition based on a truncated derivative of a membrane bound protein and process for making it
JPS6051120A (ja) * 1983-08-31 1985-03-22 Chemo Sero Therapeut Res Inst 単純ヘルペスサブユニットワクチン
US5171568A (en) * 1984-04-06 1992-12-15 Chiron Corporation Recombinant herpes simplex gb-gd vaccine
US5612041A (en) * 1984-07-17 1997-03-18 Chiron Corporation Recombinant herpes simplex gD vaccine
JPS6153226A (ja) * 1984-08-24 1986-03-17 Chemo Sero Therapeut Res Inst 単純ヘルペスサブユニツトワクチンの精製方法
ATE72123T1 (de) * 1985-04-19 1992-02-15 Wistar Inst Impfstoff fuer die erzeugung einer gegen ein virus schuetzenden immunogenen t-zellen-antwort.
GB8605390D0 (en) * 1986-03-05 1986-04-09 Univ Birmingham Live herpes simplex vaccine
EP0471778A1 (en) * 1989-05-12 1992-02-26 Ciba Corning Diagnostics Corp. Herpes simplex virus type 2-glycoprotein g proteins and polypeptides
GB9105992D0 (en) * 1991-03-21 1991-05-08 Smithkline Beecham Biolog Vaccine
US5654174A (en) * 1995-07-07 1997-08-05 Competitive Technologies, Inc. Herpes simplex virus glycoprotein D variants
AU2001286407A1 (en) * 2000-08-01 2002-03-04 University Of Pittsburgh Of The Commonwealth System Of Higher Education Antiviral compounds derived from the hsv gd protein and methods
US20030219448A1 (en) * 2002-05-24 2003-11-27 Cedars-Sinai Medical Center Peptide epitope-based vaccine for treating herpes simplex virus infections and related diseases
DK1523582T3 (da) * 2002-07-18 2009-03-02 Univ Washington Hurtig, effektiv rensning af HSV-specifikke T-lymfocytter samt HSV-antigener identificeret derved
AU2004274430A1 (en) * 2003-09-12 2005-03-31 Antigenics, Inc. Vaccine for treatment and prevention of herpes simplex virus infection
US8865185B2 (en) 2006-09-08 2014-10-21 The Trustees Of The University Of Pennsylvania Methods of use for HSV-1 and HSV-2 vaccines
CA2663109A1 (en) * 2006-09-08 2008-03-13 The Trustees Of The University Of Pennsylvania Hsv-1 and hsv-2 vaccines and methods of use thereof
US10478490B2 (en) * 2006-12-28 2019-11-19 The Trustees Of The University Of Pennsylvania Herpes simplex virus combined subunit vaccines and methods of use thereof
US20130028925A1 (en) * 2006-12-28 2013-01-31 Harvey Friedman Herpes simplex virus combined subunit vaccines and methods of use thereof
US8057804B2 (en) * 2006-12-28 2011-11-15 The Trustees Of The University Of Pennsylvania Herpes simplex virus combined subunit vaccines and methods of use thereof
JP6144448B2 (ja) * 2006-12-28 2017-06-07 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア 単純ヘルペスウイルス複合サブユニットワクチンおよびその使用方法
US9089537B2 (en) 2010-02-26 2015-07-28 The Trustees Of The University Of Pennslyvania Subunit vaccines for herpes viruses and methods of use
EP2694542A4 (en) * 2011-04-08 2014-10-08 Univ Duke HERPES SIMPLEX VIRUS
RS57420B1 (sr) 2012-05-16 2018-09-28 Immune Design Corp Vakcine za hsv-2

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4374127A (en) * 1977-09-19 1983-02-15 Merck & Co., Inc. Herpes sub unit vaccine
ES487106A0 (es) * 1978-12-22 1981-05-16 Biogen Nv Un metodo para producir al menos un polipeptido que muestra antigenicidad de hbv

Also Published As

Publication number Publication date
JPH0797396A (ja) 1995-04-11
DK172619B1 (da) 1999-03-01
FI833768A0 (fi) 1983-10-17
ES8406199A1 (es) 1984-08-01
JP2669594B2 (ja) 1997-10-29
FI83880B (fi) 1991-05-31
EP0101506B1 (en) 1990-07-25
NO172745B (no) 1993-05-24
WO1983002897A1 (en) 1983-09-01
JPS59500216A (ja) 1984-02-16
FI73885B (fi) 1987-08-31
IE830332L (en) 1983-08-18
FI73885C (fi) 1987-12-10
PH25689A (en) 1991-09-04
DE3381761D1 (de) 1990-08-30
AU554710B2 (en) 1986-08-28
IL80896A0 (en) 1987-03-31
DK479083D0 (da) 1983-10-17
JP2567202B2 (ja) 1996-12-25
ATE54827T1 (de) 1990-08-15
DK479083A (da) 1983-10-17
CA1236774A (en) 1988-05-17
NO162366B (no) 1989-09-11
KR910006889B1 (ko) 1991-09-10
HU195734B (en) 1988-07-28
FI83880C (fi) 1991-09-10
IL80895A0 (en) 1987-03-31
FI864102A0 (fi) 1986-10-10
JPH0769924A (ja) 1995-03-14
NO842962L (no) 1983-10-17
NO172745C (no) 1993-09-01
EP0101506A4 (en) 1984-07-06
ES519875A0 (es) 1984-08-01
FI864102A (fi) 1986-10-10
FI833768A (fi) 1983-10-17
IL80895A (en) 1990-02-09
IE56479B1 (en) 1991-08-14
US4762708A (en) 1988-08-09
IL67930A0 (en) 1983-06-15
NZ220771A (en) 1990-09-26
EP0101506A1 (en) 1984-02-29
IL67930A (en) 1990-02-09
NO833773L (no) 1983-10-17
AU1339683A (en) 1983-09-08
AR231496A1 (es) 1984-12-28
JP2665332B2 (ja) 1997-10-22
KR840003420A (ko) 1984-09-08
GR77900B (es) 1984-09-25

Similar Documents

Publication Publication Date Title
IL80896A (en) Synthetic polypeptides which duplicate amino acid sequences of herpes simplex virus envelope glycoproteins and vaccine composition and diagnostic reagent containing them
IL72799A0 (en) Peptides and pharmaceutical compositions containing them
GB2178041B (en) Antigenic modification of peptides
IL72785A (en) Herpes simplex virus vaccines based on glycoproteins and process for making them
JPS5772915A (en) Separation of aqueous protein mixture
PH19645A (en) New derivatives of bicyclic amino acids and pharmaceutical composition containing them
NZ205341A (en) 37 residue influenza virus peptide and vaccines
EP0332677A4 (en) Attenuated herpes viruses, herpes viruses which include foreign dna encoding an amino acid sequence and vaccines containing same
EP0085321A3 (en) Diphosphonic acid derivatives and pharmaceutical preparations containing them
IL63627A (en) Phen(alk)oxy-substituted oxiranecarboxylic acids,processes for their preparation and pharmaceutical preparations containing them
GB2171103B (en) Novel peptides and peptide derivatives, their preparation and use and pharmaceutical compositions containing them
IL74661A0 (en) Preparation of proteins
ZA835138B (en) Production of herpes simplex viral proteins
PT77014B (en) Production of herpes simplex viral proteins
GB2126224B (en) Derivatives of w-amino acids the preparation and utilisation thereof and the compositions containing these derivatives
EP0152076A3 (en) Derivative of adult t cell leukemia virus antigen peptide
EP0084822A3 (en) Diphosphonic acid derivatives and pharmaceutical preparations containing them
JPS5779897A (en) Polypeptide containing amino acid arrangement of aged human corpuscle interferone
GB2124233B (en) Synthetic peptides and their preparation
GB2161166B (en) Radiolabeling of methionine containing proteins and peptides
HK79890A (en) Prophylactic and therapeutic use of muramyl peptides and their analogues against viral infections
IL70152A0 (en) Peptides,their preparation and pharmaceutical and veterinary compositions containing them
AU1678783A (en) Production of herpes simplex viral proteins
DE3566537D1 (en) Tris(disbustituted amino)sulfonium perfluoroalkoxides and perfluoroalkylmercaptides and process for their preparation
GB2193206B (en) Preparation of taurine-containing peptides

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
EXP Patent expired